InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kevin Michael Krause, Chief Strategy Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 2 open-market SEC Form 4 transactions: 0 purchases worth $0 and 2 sales worth $201K, reported from Jan 2, 24 to Jan 9, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 24 | ANTXAN2 Therapeutics, Inc. | SELL | 7.4K | $20.14 | $149K |
| Jan 2, 24 | ANTXAN2 Therapeutics, Inc. | SELL | 2.6K | $20.12 | $52K |